ETEX Corporation

Industry:	Medical Devices & Equipment
Revenues:	$3.5 Million
Employees:	42

Description

Since 1989, ETEX Corporation has developed, manufactured and marketed proprietary, nanocrystalline calcium-phosphate-based biomaterials that promote the repair and regeneration of bone damaged by trauma or disease. Our experience and expertise in bone biology and biomaterials is the foundation for a robust, innovative, market-driven product pipeline. The current product portfolio of synthetic calcium phosphate based bone substitute materials is rapidly expanding via the accelerated development of versatile carrier technologies and osteoinductive combination products . The following themes are central to the ETEX mission:Repairing skeletal defects Regenerating bone and soft tissue Enabling controlled delivery of cells, biologics & therapeutic agents Facilitating minimally invasive procedures Developing user and patient friendly systems

View More Statistics

Site Statistics

Monthly Unique Visitors:	329
Site Rank:	2,726,906
Trust Rating:	Neutral
Stats by

News Archive

Etex, Alphatec Spine reach distribution agreement.(INDUSTRY NEWS) Biomedical Materials; 12/1/2009 Advanced biomaterials company Etex Corp signed a distribution agreement with...the terms of which Alphatec will market Etex's bone graft substitute portfolio in the USA. The agreement is non-exclusive. Etex makes calcium phosphate-based biomaterials... ...more

ETEX Corporation Announces Distribution Agreement with Alphatec Spine. PR Newswire; 11/5/2009 ...CAMBRIDGE, Mass., Nov. 5 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials...California. Alphatec Spine will market and sell ETEX's proprietary bone graft substitute portfolio...efforts will be focused on EquivaBoneA', ETEX's proprietary, certified osteoinductive... ...more

ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute. PR Newswire; 10/1/2009 ...CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials...characteristics of the clinically proven ETEX calcium phosphate osteoconductive scaffold...defect. Brian Ennis, President and CEO of ETEX Corporation, comments, "ETEX is pleased... ...more